Department of Public Health, Bologna Health Authority, via del Seminario 1, 40068 San Lazzaro di Savena, Italy.
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, via G. Massarenti 9, 40138 Bologna, Italy.
Vaccine. 2022 Sep 16;40(39):5709-5715. doi: 10.1016/j.vaccine.2022.08.039. Epub 2022 Aug 22.
The main objective of the study is to assess whether there is an increased risk of mortality in the days following the administration of COVID-19 vaccines in Bologna Health Authority in the first year of COVID-19 vaccination campaign. A secondary objective was to describe causes of deaths occurred in the days after vaccination. We conducted a retrospective observational study on all residents of Bologna Health Authority who received at least one COVID-19 vaccination dose from December 27, 2020 to December 31, 2021 and compared mortality in the 3, 7, 14 30 days after vaccination (risk interval) with the mortality in the period of the same length (3, 7, 14 and 30 days) beyond the 30th day after the last dose of vaccination (control interval). The cohort included 717,538 people. The mortality rate was 2.24 per 100 person-years during the 30 days risk interval vs 2.72 in the control interval with an adjusted incidence rate ratio equal to 0.76 (95% CI: 0.70-0.83, p < 0.001). The risk of mortality is significantly lower (p < 0.001) also in the 3, 7, 14 days risk intervals than in the control intervals. This study shows that there is no increase in mortality in the short-term period after COVID-19 vaccines.
本研究的主要目的是评估在 COVID-19 疫苗接种运动的第一年,博洛尼亚卫生局在接种 COVID-19 疫苗后几天内的死亡率是否会增加。次要目的是描述接种疫苗后几天内发生的死亡原因。我们对 2020 年 12 月 27 日至 2021 年 12 月 31 日期间至少接种过一剂 COVID-19 疫苗的博洛尼亚卫生局所有居民进行了回顾性观察性研究,并比较了接种后 3、7、14 和 30 天(风险间隔)的死亡率与接种后相同长度(3、7、14 和 30 天)的死亡率超过最后一剂疫苗接种后 30 天(对照间隔)。该队列包括 717,538 人。在 30 天风险间隔内,死亡率为每 100 人年 2.24 例,而在对照间隔内为每 100 人年 2.72 例,调整后的发病率比为 0.76(95%CI:0.70-0.83,p<0.001)。在 3、7、14 天的风险间隔内,死亡率也明显低于对照间隔(p<0.001)。本研究表明,COVID-19 疫苗接种后短期内死亡率没有增加。